Key facts
- Notable investors include Kerv Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nexia
- ·The full record, as it builds
Funding rounds
No funding rounds for Nexia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nexia
Operator of a lifesciences recruiting agency intended to hire people working across the medtech, diagnostics, pharmaceuticals, and biotherapeutics fields. The company engages in hiring individuals who combine technical expertise, leadership, and emotional intelligence, helping life sciences companies secure talent equipped to lead through complexity and change.
- Sector
- Business Products and Services (B2B)
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 4
- Ownership
- Privately Held (backing)
Nexia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nexia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nexia in its N-PORT filings yet. We sweep new filings monthly.